Grant Gibson

Biography

Grant Gibson is an experienced finance executive with over 20 years of progressive global experience focused on the biotech, pharma and life science industries.  Grant has overall responsibility for all areas of finance and the day-to-day operations of Triphase, including strategic financial planning, audit & accounting, tax, and treasury as well as human resources. Most recently, Grant was the CFO of Clearstone Central Laboratories – a private global central laboratory business spun-out from MDS Inc. Before joining Clearstone, Grant held senior finance positions with MDS Inc. – a large Canadian public CRO business, and Elan Pharmaceuticals – a global public pharmaceutical company focused on neurodegenerative and autoimmune diseases.  Prior to entering industry, Grant was a valuation expert for Deloitte & Touche in San Francisco, providing valuation consulting services to many leading global pharma/biotech and technology companies. Grant began his career with Ernst & Young and held various positions of increasing responsibility in the firm’s Corporate Finance and Audit & Assurance practice areas in both Canada and the United States. Grant obtained his Honors Business Administration (HBA) degree from the Richard Ivey School of Business at the University of Western Ontario and is a Chartered Professional Accountant (CPA) and Chartered Business Valuator (CBV).

Research Interest

Biotech, pharma and life science industries